Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Sanofi-Aventis Menactra Approved; Launch Awaits ACIP Recommendations

Jan 24 2005

• By The Pink Sheet

Related Content

Aventis Pegs Injectable Flu Vaccine As Key Sales Growth Driver

Oct 06 2003

Sanofi-Aventis Menactra Market Is $3.5 Bil. Over 10 Years, CDC Says

Nov 08 2004

Menactra Needs Long-Term Safety, Efficacy Studies Post-Approval – Cmte.

Sep 27 2004

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window